Cenetron Announces Launch of ARCHIVA BioLogistics
News Sep 15, 2013
Archiva Biologistics will focus on the design and manufacture of clinical collection kits, innovative laboratory requisition documents, sample logistics, and sample storage. All facets of Archiva are operationally linked and managed with GlobeSyncTM, an enterprise-wide 21-CFR-part 11 compliant Laboratory Information Management System, and Manufacturing software platform. GlobeSync is a proprietary software system and data portal developed at Cenetron Diagnostics.
Archiva will be housed in a recently completed 42,000 sq. foot facility, with state-of-the art manufacturing and sample storage capabilities.
Archiva customers are able to utilize individual services, such as kit building or sample storage, or can take advantage of a full complement of services from protocol review, kit design, sample logistics, sample storage, and testing.
New customers to Archiva include pharma and biotech companies, national reference laboratories, in-vitro diagnostic companies, and academic institutions.
Dwight DuBois, CEO, commented, “Archiva BioLogistics has been in development for several years. We recognized that high quality, cost containment, and maximum efficiency of clinical trial and reference laboratory work starts with flawless sample collection, transportation, and storage practices. We have come up with innovative, user-friendly answers to this common problem, based largely on feedback from customers with unmet needs.”
Vice President of Operations Brandon Harper commented, “By utilizing proven processes and best practices developed at Cenetron, Archiva is able to provide a complete sample management solution for a project of any size and for any location worldwide. Many of Archiva’s new clients are from outside our traditional pharma client base, and include diagnostic companies, specialty laboratories, and academic institutions.”
Cenetron Diagnostics is a premier provider of molecular laboratory services, providing support for anti-viral and oncology drug development programs, and pharmacogenomics. Founded in 1995, Cenetron has supported pivotal global trials in North and South America, Europe, Africa and the Pacific Rim. Cenetron's client list includes leading pharmaceutical clients in the United States and Europe.
The Genes That Make Quorn a Fungal Food FavoriteNews
The meat substitute Quorn is derived from a fungus called Fusarium venenatum. A very similar fungus, F. graminearum, is one of the world's most damaging crop diseases. A new genome study shows why one fungus makes food, and the other destroys it.READ MORE
Neural Computer Hears Like HumansNews
Modelling the human senses is an incredibly complex task. Our brains arrange cells into complex hierarchies that process information from our surroundings. Now, a group at MIT have created a model of the human auditory cortex that can hear sounds and music in the same way that humans do.READ MORE
Stable Beta-Amyloid Dimers Identified in Alzheimer’s BrainsNews
A recent study exploited state-of-the-art mass spectrometry to provide the first direct evidence of beta-amyloid dimers in patients with Alzheimer’s disease and points to the potential of these molecules as biomarkers. Beta-amyloid dimers may be the smallest pathological species that trigger Alzheimer’s disease.
Comments | 0 ADD COMMENT
International Conference on Analytical and Bio Analytical Techniques
Oct 31 - Nov 01, 2018